JUL 26, 2018 10:30 PM PDT

Cannabinoids for Dementia

WRITTEN BY: Mauri Brueggeman

One area of interest in the last year, as medical cannabis moves into the mainstream, is the use of cannabinoids for the treatment of dementia.  To be clear, many of the scientists or providers looking to cannabis or cannabinoid products are really looking at treating the symptoms associated with dementia, rather than the cause of dementia itself.  According to the literature, around half of patients with dementia experience behavioral and psychological symptoms (BPSD) which are distressing for everyone involved including the patient, caregivers, and family.  While it is widely accepted to use anti-psychotics for these patients, many patients do not show significant improvement and suffer grave side effects as a result of that group of pharmaceuticals used.

There are many scientists itching to explore the use of cannabinoids for the treatment of dementia because of their connection to our own endocannabinoid system (ECS), which maintains many physiological balances within our bodies.  There have been multiple neurological benefits connected to and documented as being a result of cannabinoid presence in the body.  One of the critical roles of the ECS is regulation of message transmission via our cellular synapses.  The ECS has multiple components: already somewhat understood endocannabinoids including 2-arachidonoyl glycerol (2-AG) and anandamide, cannabinoid receptors (CB1 and CB2), and enzymes involved in the regulation and metabolism of endocannabinoids.

Phytocannabinoids, like tetrahydrocannabinol (THC) and cannabidiol (CBD), affect the ECS through use or agonistic action on the cannabinoid receptors located in the body.  It has been suggested that some of these ECS components, CB2 for example, have specific neuroprotection features and that these neuroprotective effects counteract the neurodegenerative process involved in many forms of dementia.  Researchers have even documented reduction in CB1 levels within the nervous system of patients with dementia.  One group of researchers found changes in expression and distribution of CB1 in Alzheimer’s patients.  In fact, THC decreases the amyloid beta-peptide aggregates characteristically found in Alzheimer’s patients.  In these data sets, the research points to cannabinoids having a direct effect on the pathogenesis of disease. 

In other types of dementia where pathogenesis is less well understood, cannabinoids have been suggested to provide relief from the common BPSD felt by patients and those close to them including depression, anxiety, agitation, aggression, wandering, issues sleeping, and others. 

Sources: Neurodegenerative Disease Management, Cochrane Database of Systematic Reviews,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAY 06, 2021
Cannabis Sciences
New CBD Analog Outperforms Regular CBD for Pain Relief
MAY 06, 2021
New CBD Analog Outperforms Regular CBD for Pain Relief
Researchers from Temple University Health System have found that a novel cannabidiol (CBD) analog can reverse pain sensi ...
MAY 19, 2021
Cannabis Sciences
Cannabis May Reduce Pain in Treatment-Resistant Fibromyalgia
MAY 19, 2021
Cannabis May Reduce Pain in Treatment-Resistant Fibromyalgia
An Italian researcher found that long-term use of various cannabis products, including herbal cannabis and oil extracts, ...
JUN 08, 2021
Cannabis Sciences
Can Smoking Weed Help You Lose Weight?
JUN 08, 2021
Can Smoking Weed Help You Lose Weight?
While cannabis is known to increase appetite in what is known as the ‘munchies’, some say they are able to l ...
JUN 12, 2021
Health & Medicine
Teenagers With Sleep Issues More Likely to Use Cannabis
JUN 12, 2021
Teenagers With Sleep Issues More Likely to Use Cannabis
Teenagers are renowned for going to bed late and sleeping in. But if disrupted sleep gets out of hand for young people, ...
JUN 19, 2021
Health & Medicine
Medical Cannabis Impairs Drivers No More Than Common Meds
JUN 19, 2021
Medical Cannabis Impairs Drivers No More Than Common Meds
 Most people wouldn’t think it highly irresponsible to get behind the wheel after having taken a dose of cold ...
JUL 05, 2021
Cannabis Sciences
Prenatal Cannabis Exposure Lessens Effects of Antidepressants
JUL 05, 2021
Prenatal Cannabis Exposure Lessens Effects of Antidepressants
Researchers at Indiana University have found that mice exposed to cannabinoids while in the womb are less responsive to ...
Loading Comments...